✦ LIBER ✦

194 Characterization and preclinical development of LY2606368, a second generation Chk1 inhibitor

✍ Scribed by M. Marshall; C. King; D. Barnard; H. Diaz; D. Barda; A. Bence; E. Westin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization and preclinical develop

✍ King, Constance; Diaz, Henry; Barnard, Darlene; Barda, David; Clawson, David; Bl 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 969 KB

Preclinical characterization of LY288672

✍ Patrick May; Leonard Boggs; Richard Brier; David Calligaro; Martin Citron; There 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Preclinical characterization of LY288672

✍ May, Patrick; Boggs, Leonard; Brier, Richard; Calligaro, David; Citron, Martin; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Sa.98. Preclinical and Clinical Developm

✍ Joseph Kovalchin; Jeffrey Krieger; Ingrid Dufour; Kathy Collins; Michelle Genova 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Research and Development of a Second-Gen

✍ Harrington, Peter J.; Brown, Jack D.; Foderaro, Tommaso; Hughes, Robert C. 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 98 KB

Development of a second-generation genet

✍ E. Dirlewanger; P. Cosson; K. Boudehri; C. Renaud; G. Capdeville; Y. Tauzin; F. 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 452 KB